Notably, GWAS have shown that LRRK2 is also a susceptibility gene for IBD, and IBD is associated with an increased risk of PD (Umeno et al., 2011; Zhu et al., 2019). This evidence concerns the gene LRRK2 and inflammatory bowel disease.